The culmination of 15 years of research

After 15 years of research, Ablatherm HIFU is regarded among the world’s top therapeutic solutions for prostate cancer. This revolutionary treatment is the result of a collaboration between the INSERM, l’Hôpital Edouard Herriot in Lyons and EDAP TMS. Their work has led to the design of a technically advanced therapeutic tool that provides patients with a new non-invasive treatment based on High Intensity Focused Ultrasound, or HIFU.

After 15 years of research Ablatherm HIFU is considered safe, effective, and clearly among the best therapeutic solutions.